Business Context and Reporting Period
Company: Amerigon Incorporated (Note: Input metadata referenced "Gentherm Inc," but the filing text identifies the registrant as Amerigon Incorporated).
Reporting Period: Quarterly period ended March 31, 2009 (Form 10-Q).
Business Overview: Amerigon designs and markets products based on proprietary thermoelectric device (TED) technologies. Its principal product is the Climate Control Seat (CCS), sold to automotive OEMs and tier-one suppliers for active heating and cooling. As of March 2009, the CCS was offered on 41 automobile models. The company also holds an 85% interest in BSST LLC, a subsidiary focused on advanced TED research and development.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Product Revenues | $10.17 million | $17.36 million |
| Gross Margin | $2.42 million (24%) | $5.56 million (32%) |
| Operating Income (Loss) | ($1.48 million) | $1.84 million |
| Net Income (Loss) | ($0.94 million) | $1.37 million |
| Diluted EPS | ($0.04) | $0.06 |
| Cash & Equivalents (End of Period) | $25.19 million | $2.56 million |
| Working Capital | $29.88 million | N/A (Derived from Q4 2008: $30.47 million) |
| Debt (Revolving Credit Line) | $1.30 million | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Product revenues decreased 41% to $10.17 million, driven by a 43% drop in unit shipments (143,000 units vs. 253,000 units). This was primarily due to a significant decline in the global automotive market and reduced inventory purchases by Asian customers.
- Margin Compression: Gross margin percentage fell from 32% to 24%. Contributing factors included higher raw material costs (specifically Tellurium), an unfavorable product mix favoring lower-margin programs, and lower fixed cost coverage due to reduced volumes.
- Operating Loss: The company reported an operating loss of $1.48 million compared to an operating income of $1.84 million in the prior year. Net R&D expenses increased 10% due to advanced TED program activities.
- Liquidity Position: Cash and cash equivalents increased significantly to $25.19 million from $2.56 million in Q1 2008, bolstered by a $1.3 million draw on the revolving credit line and stock option exercises.
Outlook, Risks, and Management Commentary
- Outlook: Management anticipates an operating loss for the second quarter of 2009 due to continued declines in expected product revenue. They expect Tellurium costs to remain elevated until suppliers work off inventory, potentially through Q3 2009.
- Liquidity Strategy: The company intends to repay the $1.3 million credit line draw in Q2 2009 using cash reserves. Management believes current working capital and the $20 million credit facility are adequate for foreseeable needs.
- Key Risks:
- Automotive Industry Downturn: Significant production declines by OEMs, particularly in North America, directly impact revenue.
- Bankruptcy Risk: Potential bankruptcy of major domestic automotive manufacturers could result in uncollectible receivables and loss of future revenue.
- Raw Material Volatility: Prices for Tellurium, a key component, remain a cost pressure.
- Single Product Reliance: The CCS is the only commercially successful product; diversification into other industries (e.g., bedding with Sealy) is in development but not yet a revenue driver.
- Unusual Items: The company adopted a Shareholder Rights Plan (Poison Pill) in January 2009 to deter coercive takeover tactics.
Investor Verification Checklist
- Verify the status of major automotive OEM customers (Ford, GM, Toyota) regarding production schedules and financial stability.
- Monitor Tellurium market prices and supplier contract terms to assess future gross margin pressure.
- Review the progress of the Sealy Corporation bedding development agreement and other non-automotive TED applications.
- Confirm the company's ability to maintain liquidity if the credit market tightens further or if the revolving credit line lender fails to honor commitments.
- Assess the impact of the Shareholder Rights Plan on potential M&A activity or stock liquidity.